News
ICViewExpert PerspectivesMedical World NewsVideosWebinars
Conferences
Infection Control TodaySupplements And Featured Publications
CME/CEEditorial Advisory BoardJob BoardPartnersSponsoredWhitepapers
Print SubscriptioneNewsletter
Educator of the Year Nomination FormEducator of the Year Official RulesEducator of the Year
Advanced TechnologyAdvanced TechnologyAdvanced Technology
Bug of the Month
COVID-19
Environmental Services
HAIs
Hand Hygiene
Long-Term Care
Operating Room
Personal Protective EquipmentPersonal Protective Equipment
PreventionPrevention
Sterile Processing
Surface Disinfection
Vascular Access
Spotlight -
  • Expert Perspectives on Personal Protection Guidelines and Standardization Practices
  • Bug of the Month
Advanced TechnologyAdvanced TechnologyAdvanced Technology
Bug of the Month
COVID-19
Environmental Services
HAIs
Hand Hygiene
Long-Term Care
Operating Room
Personal Protective EquipmentPersonal Protective Equipment
PreventionPrevention
Sterile Processing
Surface Disinfection
Vascular Access
    • News
    • Conferences
Advertisement

Shingles May be Related to Elevated Risk of Multiple Sclerosis

June 8, 2011
Article

Taiwanese investigators have found that there can be a significantly higher risk of multiple sclerosis (MS) occurring in the year following a shingles, or herpes zoster, attack. The findings, which support a long-held view on how MS may develop, are published in the Journal of Infectious Diseases.

MS is an autoimmune disease that affects the brain and spinal cord, leading to inflammation and nerve damage as the bodys immune cells attack the nervous system. Possible causes that may trigger the inflammation include environmental, genetic, and viral factors. One virus that has been associated with MS is varicella zoster virus, the cause of herpes zoster.

In a study conducted by Herng-Ching Lin, PhD, and colleagues at Taipei Medical University in Taiwan, 315,550 adults with herpes zoster and a control group of 946,650 subjects were tracked and then evaluated for MS occurrence during a one-year follow-up period. The control group was selected randomly from a pool of subjects who had not been diagnosed with herpes zoster or other viral diseases. After adjusting for monthly income and geographic region, the authors found that the group with herpes zoster had a 3.96 times higher risk of developing MS than the control group. The authors noted that this risk, although increased, was still low, as is the frequency of MS in general. The study also noted an interval of approximately 100 days between a herpes zoster event and occurrence of MS.

Although the study was limited almost entirely to Han Chinese adults, the large scope of this nationwide case-controlled study, 1.26 million sampled patients, provides strong epidemiological evidence for a possible role for herpes zoster in the development of MS. The authors also point out that MS has a lower prevalence in Asian compared to Western populations and, thus, it may be difficult to project their findings to other populations.

In an accompanying editorial, Teresa Corona, MD, and Jose Flores, MD, of the National Institute of Neurology and Neurosurgery in Mexico noted that "The evidence provided in this studyallows us to better understand the role of these viral factors as an MS risk among certain genetically susceptible individuals," and that the study should be corroborated in other parts of the world to help clarify the role of this and other viruses in MS.

Related Videos
NFID Medical Director, Robert H. Hopkins, Jr., MD  (Photo courtesy by Evoke Kyne)
Shelley Summerlin-Long, MPH, MSW, BSN, RN, senior quality improvement leader, infection prevention, UNC Medical Center, Chapel Hill, North Carolina
Infection Control Today Infection Intel: Staying Ahead with Company updates and product Innovations.
An eye instrument holding an intraocular lens for cataract surgery. How to clean and sterilize it appropriately?   (Adobe Stock 417326809By Mohammed)
Christopher Reid, PhD  (Photo courtesy of Christopher Reid, PhD)
Paper with words antimicrobial resistance (AMR) and glasses.   (Adobe Stock 126570978 by Vitalii Vodolazskyi)
3D illustration: Candida auris   (Adobe Stock 635576411 By Niamh )
 MIS-C (Adobe Stock 350657530 by Bernard Chantal)
Set of white bottles with cleaning liquids on the white background. (Adobe Stock 6338071172112 by zolnierek)
Related Content
Advertisement

Turbine structure model with cross-section   (Adobe Stock 137387581 by evannovostro)

Implementing Infection Control Protocols in Turbomachinery Manufacturing Environments

December 8th 2023
Article

Explore the challenges and innovations in infection control protocols for turbomachinery manufacturing. Discover the role of automation, IoT, and employee training in safeguarding health and productivity.


Weekly Rounds with Infection Control Today

Weekly Rounds: Challenging MRSA Precautions, Bug of the Month, and More

December 8th 2023
Article

Take 5 minutes to catch up on Infection Control Today®’s highlights for the week ending December 10, 2023.


A woman wearing a mask and holding petri dishes.    (Adobe Stock 630899781 by Basily Merkushev)

Chief Infection Prevention Officer: Leading the Way Into the Future

December 7th 2023
Article

The role and responsibility of executive-level oversight in infection prevention is growing. Expertise, determination, consistency, and sustainability bring value to reducing healthcare–associated infections, preventing harm, and supporting a safe workplace.


COVID-19 words in green and blue.  (Adobe Stock 331001452 by Web Buttons Inc)

Assessing Measures for Reducing SARS-CoV-2 Transmission: Low- and High-Tech Tools and Practical Insights

December 6th 2023
Article

Which of the various low and high-tech measures proposed to mitigate SARS-CoV-2 transmission, from hand hygiene to air cleaners, actually work? A new study gives practical tools for assessment and insights into their effectiveness.


Jo Varshney, the founder of VeriSIM Life (Photo credit to VeriSIM Life)

VeriSIM Life's Founder, Jo Varshney, DVM, PhD, Honored as Most Innovative Woman in Health Care

December 6th 2023
Article

Jo Varshney, DVM, PhD, the founder of VeriSIM Life, shares her journey to her current position and the role of courage in it.


Infection Control Today's Infection Intel

Infection Intel: BiomX, SHEA, CSL and Arcturus Therapeutics

December 5th 2023
Article

Staying Ahead with Company Updates and Product Innovations. This article's news is from BiomX, SHEA, and CSL and Arcturus Therapeutics.

Related Content
Advertisement

Turbine structure model with cross-section   (Adobe Stock 137387581 by evannovostro)

Implementing Infection Control Protocols in Turbomachinery Manufacturing Environments

December 8th 2023
Article

Explore the challenges and innovations in infection control protocols for turbomachinery manufacturing. Discover the role of automation, IoT, and employee training in safeguarding health and productivity.


Weekly Rounds with Infection Control Today

Weekly Rounds: Challenging MRSA Precautions, Bug of the Month, and More

December 8th 2023
Article

Take 5 minutes to catch up on Infection Control Today®’s highlights for the week ending December 10, 2023.


A woman wearing a mask and holding petri dishes.    (Adobe Stock 630899781 by Basily Merkushev)

Chief Infection Prevention Officer: Leading the Way Into the Future

December 7th 2023
Article

The role and responsibility of executive-level oversight in infection prevention is growing. Expertise, determination, consistency, and sustainability bring value to reducing healthcare–associated infections, preventing harm, and supporting a safe workplace.


COVID-19 words in green and blue.  (Adobe Stock 331001452 by Web Buttons Inc)

Assessing Measures for Reducing SARS-CoV-2 Transmission: Low- and High-Tech Tools and Practical Insights

December 6th 2023
Article

Which of the various low and high-tech measures proposed to mitigate SARS-CoV-2 transmission, from hand hygiene to air cleaners, actually work? A new study gives practical tools for assessment and insights into their effectiveness.


Jo Varshney, the founder of VeriSIM Life (Photo credit to VeriSIM Life)

VeriSIM Life's Founder, Jo Varshney, DVM, PhD, Honored as Most Innovative Woman in Health Care

December 6th 2023
Article

Jo Varshney, DVM, PhD, the founder of VeriSIM Life, shares her journey to her current position and the role of courage in it.


Infection Control Today's Infection Intel

Infection Intel: BiomX, SHEA, CSL and Arcturus Therapeutics

December 5th 2023
Article

Staying Ahead with Company Updates and Product Innovations. This article's news is from BiomX, SHEA, and CSL and Arcturus Therapeutics.

Advertise
About Us
Editorial Board
Contact Us
Job Board
Terms and Conditions
Privacy
Do Not Sell My Personal Information
Contact Info

2 Clarke Drive
Cranbury, NJ 08512

609-716-7777

© 2023 MJH Life Sciences

All rights reserved.
Home
About Us
News